Neurocrine Biosciences reported $1.37B in Equity Capital and Reserves for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US $ 1291.97M 102.79M
Aptinyx Inc APTX:US $ 77.48M 17.27M
Cytokinetics CYTK:US $ 116.26M 127.6M
Enanta Pharmaceuticals ENTA:US $ 358.58M 25.8M
IONIS PHARMACEUT IONS:US $ 772M 241.46M
Nektar Therapeutics NKTR:US $ 679.51M 122.03M
Prothena PRTA:US $ 438.89M 27.16M
Teva Pharmaceutical TEVA:IT 10.28B 189M
Xoma XOMA:US $ 139.92M 1.95M